VivoCAR™ Anti-CD229 (1D5) h(CD28-41BB-CD3z) CAR saRNA (XS-0326-XU108)

Name: VivoCAR™ Anti-CD229 (1D5) h(CD28-41BB-CD3z) CAR saRNA
SKU: XS-0326-XU108
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

VivoCAR™ Anti-CD229 (1D5) h(CD28-41BB-CD3z) CAR saRNA utilizes an saRNA backbone to express the 1D5 clone. For in vivo therapy, the 1D5 clone is essential for its rapid binding kinetics and high affinity to CD229. By utilizing the biological magnification effect of saRNA, the product maintains high CAR density on redirected T cells through intracellular replication. This facilitates efficient in situ reprogramming and providing a sustained immune response against CD229-positive B-lineage malignancies.

Add to Cart

CAR Information

Target
CD229

Target Species
Human

Antibody Clone
1D5

scFv Host Species
Human

Receptor Construction
CD28-41BB-CD3z

Generation
Third

Description of Signaling Cassetes
The third-generation CD28-41BB-CD3ζ architecture employs a sequential costimulatory strategy, where the CD28 module drives rapid initial activation and metabolic reprogramming, while the 4-1BB component sustains long-term cellular viability and mitigates exhaustion. This tandem design, anchored by the CD3ζ signaling chain, synergistically amplifies downstream signal transduction, resulting in a balanced T-cell phenotype with robust effector capacity and prolonged durability. The integrated signaling cascade thus optimizes both kinetic expansion and persistence, enhancing antitumor efficacy.

CAR saRNA Properties

Structure
Linear

Cap
Cap 1

PolyA
Segmented PolyA

Product Type
CAR IVT saRNA

Concentration
Lot specific

Buffer
1 mM Sodium Citrate, pH 6.4 (or specialized RNA storage buffer, RNase-free).

Storage
Aliquot and store at -80°C. Avoid freeze/thaw cycles.

Handling
Thaw and work with RNA on ice. Upon first use, pulse spin before opening and aliquot into single use portions. DO NOT vortex. Use only certified RNase-free reagents and consumables with proper RNase-free technique. Use of barrier tips is recommended. Avoid freeze/thaw cycles. DO NOT mix with media containing serum unless first complexed with a stabilizing transfection reagent.

saRNA Quality Control

IVT Vector Sequencing
Pass

IVT Vector Enzyme Digestion
Pass

Purity OD260/280
Pass

RNA Length and Integrity Assessment (Determined by Denaturing Agarose Gel Electrophoresis)
Pass

RNA Sequence Assessment
Pass

Endotoxin (<10 EU/mg)
Pass

In Vitro Transfection and Expression (Optional)
Pass

Target Information

Full Name
Cluster of Differentiation 229

Alternative Names
LY9; SLAMF3; hly9; mLY9

Introduction
CD229 is a member of the SLAM family of receptors. it is highly expressed on multiple myeloma cells and leukemic stem cells, making it a critical target for eliminating the reservoir of disease-initiating cells.

Targeting Diseases
Multiple Myeloma (MM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Plasma Cell Leukemia

UniProt ID
Q9HBG7

Gene ID
4063

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for VivoCAR™ Anti-CD229 (1D5) h(CD28-41BB-CD3z) CAR saRNA (XS-0326-XU108). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.